Johne's disease - Symptoms, Causes, Treatment & Prevention

```html

Overview

Johne’s disease (also called paratuberculosis) is a chronic, progressive infection of the small intestine caused by the bacterium Mycobacterium avium subspecies paratuberculosis (MAP). While the disease is most widely recognized in ruminant livestock—especially cattle, sheep, and goats—it can also affect humans, albeit rarely, where it is sometimes described as “human paratuberculosis.”

In animals, Johne’s disease is a major cause of wasting, reduced milk production, and early culling, representing an economic loss estimated at US $200 million–$1 billion globally each year (FAO, 2022). Human cases are far less common; epidemiological surveys suggest a prevalence of < 0.1 % in the general population, with higher rates in individuals with certain chronic gastrointestinal disorders such as Crohn’s disease (CDC, 2023).

Because the infection progresses slowly—often taking years from exposure to clinical disease—early recognition is essential. The disease is not contagious from person to person; transmission occurs primarily through ingestion of MAP‑contaminated food, water, or milk.

Symptoms

Symptoms differ between animals and humans. The guide below lists the most frequently reported manifestations in people.

• Chronic diarrhea – watery or loose stools lasting months; may be intermittent.
• Weight loss & cachexia – gradual loss of body mass despite normal or increased appetite.
• Abdominal pain or cramping – often post‑prandial and may mimic irritable bowel syndrome.
• Fatigue & malaise – persistent tiredness not explained by other conditions.
• Nausea & loss of appetite – can lead to reduced nutritional intake.
• Low‑grade fever – occasional temperature spikes (37.5‑38.5 °C).
• Microscopic blood in stool – usually occult; visible blood is rare.
• Joint pain (arthralgia) – reported in a minority of patients, possibly due to systemic inflammation.
• Growth retardation (children) – delayed height and weight gain.

Symptoms often overlap with Crohn’s disease, ulcerative colitis, and other inflammatory bowel disorders, making laboratory testing essential for a definitive diagnosis.

Causes and Risk Factors

Human infection is acquired by ingesting MAP from environmental sources:

• Contaminated dairy products – unpasteurized milk, cheese, or ice‑cream.
• Undercooked meat – especially from infected ruminants.
• Water – untreated or poorly filtered water supplies contaminated with animal waste.
• Occupational exposure – farmers, veterinarians, abattoir workers, and dairy processors are at heightened risk.

Other risk factors that increase susceptibility include:

• Genetic predisposition – certain HLA‑DR and NOD2 variants linked to Crohn’s disease also appear to increase MAP infection risk (NIH, 2022).
• Immunosuppression – HIV infection, organ transplantation, or long‑term corticosteroid use may allow MAP to establish chronic infection.
• Young age at exposure – ingestion during childhood may lead to a longer incubation period and more severe disease later in life.

Diagnosis

Because symptoms are nonspecific, a combination of clinical, laboratory, and imaging studies is required.

1. Medical History & Physical Exam

Clinicians assess duration of diarrhea, weight trends, dietary habits, occupational exposure, and any history of animal contact.

2. Laboratory Tests

• Stool cultures for MAP – the gold‑standard but technically demanding; positivity ranges 30‑60 % in confirmed cases.
• Polymerase Chain Reaction (PCR) for MAP DNA – highly sensitive; can be performed on stool, blood, or biopsy samples.
• Serologic assays (ELISA for MAP antibodies) – useful for screening, though cross‑reactivity may occur.
• Complete blood count (CBC) – often reveals mild anemia and leukocytosis.
• Inflammatory markers – elevated C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR).

3. Endoscopic Evaluation

Colonoscopy with ileal intubation allows direct visualization and biopsy of the terminal ileum, where MAP preferentially colonizes. Histology may show:

• Granulomatous inflammation (non‑caseating granulomas)
• Macrophages laden with acid‑fast bacilli on Ziehl‑Neelsen staining

4. Imaging Studies

Magnetic resonance enterography (MRE) or computed tomography (CT) enterography can identify thickened intestinal walls, strictures, or fistulae—findings that overlap with Crohn’s disease.

5. Differential Diagnosis

Physicians must rule out other causes of chronic diarrhea, including:

• Inflammatory bowel disease (Crohn’s, ulcerative colitis)
• Infectious enteritis (e.g., Clostridioides difficile, Giardia)
• Malabsorption syndromes (celiac disease, pancreatic insufficiency)
• Microscopic colitis

Treatment Options

There is no universally curative therapy for Johne’s disease in humans, but several approaches aim to control bacterial load, reduce inflammation, and improve quality of life.

Antibiotic Regimens

Most clinicians use a combination of antimycobacterial drugs, often modeled after multidrug regimens for tuberculosis:

• Rifabutin (300 mg daily) – penetrates macrophages and inhibits MAP RNA polymerase.
• Clarithromycin (500 mg twice daily) – macrolide with activity against MAP.
• Azithromycin or Metronidazole – added in refractory cases.

Therapy typically continues for 12–18 months, and monitoring of liver function and drug levels is essential.

Anti‑Inflammatory Agents

To manage intestinal inflammation:

• 5‑ASA (mesalamine) – mild to moderate disease.
• Systemic corticosteroids – short‑term “bridge” therapy for flares.
• Biologic agents (e.g., infliximab, ustekinumab) – may be considered when disease mimics Crohn’s and is refractory to antibiotics.

Nutritional Support

• High‑calorie, high‑protein diet – combats cachexia.
• Elemental or semi‑elemental formulas – useful for patients with severe malabsorption.
• Vitamin & mineral supplementation – especially B12, iron, calcium, and vitamin D.

Probiotic and Prebiotic Adjuncts

Limited data suggest that certain probiotic strains (e.g., Lactobacillus rhamnosus GG) may modestly reduce MAP shedding, but they are not substitutes for antibiotics.

Surgical Intervention

Reserved for complications such as strictures, perforation, or refractory disease. Resection of diseased ileal segments can improve symptoms but does not eradicate MAP elsewhere in the gut.

Living with Johne’s Disease

Effective self‑management focuses on nutrition, medication adherence, and monitoring for complications.

• Medication calendar – use a pill organizer or smartphone reminder to avoid missed doses.
• Regular follow‑up – at least every 3 months to assess weight, stool pattern, and laboratory parameters.
• Hydration – aim for 2–3 L of fluid daily; oral rehydration solutions help replace electrolytes lost in diarrhea.
• Dietary modifications – low‑residue, low‑fat meals; avoid high‑lactose dairy unless proven tolerable; consider a gluten‑free trial if celiac disease is suspected.
• Physical activity – gentle aerobic exercise (walking, swimming) improves appetite and muscle mass.
• Stress management – chronic illness can worsen gastrointestinal symptoms; mindfulness, yoga, or counseling may be beneficial.
• Vaccinations – keep immunizations up‑to‑date (influenza, pneumococcal, COVID‑19) because patients often have compromised immunity.

Prevention

Because human disease originates from environmental exposure, prevention largely mirrors food‑safety and occupational hygiene practices.

• Pasteurize all dairy products – MAP survives standard pasteurization at 72 °C for 15 s, but higher‑temperature short‑time (HTST) or ultra‑high temperature (UHT) processes greatly reduce bacterial load.
• Cook meat thoroughly – internal temperature of 71 °C (160 °F) for ground beef; 63 °C (145 °F) for whole cuts, followed by a 3‑minute rest.
• Safe water – use filtered or boiled water in areas with known livestock contamination.
• Personal protective equipment (PPE) – gloves, masks, and hand‑washing for farm workers handling manure or animal tissues.
• Farm biosecurity – separate young animals from older, MAP‑positive stock; remove manure promptly.
• Public awareness – educational campaigns in high‑risk regions (e.g., rural parts of North America, Europe, and Oceania) have reduced incidence by 15 % over the past decade (WHO, 2021).

Complications

If left untreated or poorly controlled, Johne’s disease can lead to:

• Severe malnutrition – protein‑energy deficiency, micronutrient deficits, and anemia.
• Intestinal strictures – causing obstructive symptoms and requiring surgical bypass.
• Fistula formation – abnormal connections between the intestine and bladder, skin, or other bowel loops.
• Perforation & peritonitis – life‑threatening emergency.
• Secondary infections – due to impaired immunity and mucosal barrier loss.
• Increased risk of colorectal cancer – chronic inflammation is an established risk factor; surveillance colonoscopy is advisable after 8–10 years of disease.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention (CDC). Paratuberculosis (Johne’s Disease) in Humans. 2023.
• Food and Agriculture Organization (FAO). Livestock Diseases and Economic Impact. 2022.
• National Institutes of Health (NIH). “Genetic Susceptibility to Mycobacterium avium subsp. paratuberculosis.” Journal of Gastroenterology, 2022.
• World Health Organization (WHO). Guidelines for Food Safety and Mycobacterial Contamination. 2021.
• Mayo Clinic. “Crohn’s disease – Symptoms and causes.” Updated 2024.
• Cleveland Clinic. “Chronic Diarrhea – Evaluation and Management.” 2023.

```